HIV vaccine (TBC-3B, Therion Biologics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHIV vaccine (TBC-3B, Therion Biologics)
Drug Alias Namemultigenic DNA/MVA prime/boost vaccine - TherionTBC-3BDNA prime/MVA boost vaccine - TherionRecombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)Recombinant MVA-fowlpox HIV-1 vaccine - Therion
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTherion BiologicsNational Institute of Health, Islamabad
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthTherion BiologicsNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A